Cargando…
A nomogram based on pretreatment clinical parameters for the prediction of inadequate biochemical response in primary biliary cholangitis
BACKGROUND: Ursodeoxycholic acid (UDCA) has been widely recommended as the first‐line drug for primary biliary cholangitis (PBC) in the current guidelines. However, its therapeutic effects are poor in nearly one‐third of patients. The early identification and intervention of these patients is crucia...
Autores principales: | Tian, Siyuan, Liu, Yansheng, Sun, Keshuai, Zhou, Xia, Ma, Shuoyi, Zhang, Miao, Zhou, Xinmin, Wang, Lu, Han, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676192/ https://www.ncbi.nlm.nih.gov/pubmed/32915500 http://dx.doi.org/10.1002/jcla.23501 |
Ejemplares similares
-
An enhanced level of LAMP-2A participates in CD4(+)T cell hyperactivity in patients with primary biliary cholangitis
por: Sun, Keshuai, et al.
Publicado: (2021) -
Immunoglobulin M: A Neglected Serum Biomarker in Treatment‐Naive Primary Biliary Cholangitis With Normal Alkaline Phosphatase
por: Ding, Dawei, et al.
Publicado: (2022) -
Symptoms Burden and Health-related Quality of Life in Chinese Patients with Primary Biliary Cholangitis
por: Liu, Yansheng, et al.
Publicado: (2021) -
Systematic Construction and Validation of an RNA-Binding Protein-Associated Model for Prognosis Prediction in Hepatocellular Carcinoma
por: Tian, Siyuan, et al.
Publicado: (2021) -
Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis
por: Martinez-Gili, Laura, et al.
Publicado: (2023)